GIGA-2339
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GIGA-2339, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection [Phase 1]